Development of heterodimeric estrogen receptor alpha antagonists to target simultaneously the ligand and coactivator binding site
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Development of heterodimeric estrogen receptor alpha antagonists to target simultaneously the ligand and coactivator binding site ; day:12 ; month:05 ; year:2023 ; extent:15
Archiv der Pharmazie ; (12.05.2023) (gesamt 15)
- Creator
-
Hörmann, Nikolas
Kalchschmid, Christina
Grabher, Patricia
Grassmayr, Isabella
Kapitza, Paul
Kaserer, Teresa
Gust, Ronald
- DOI
-
10.1002/ardp.202200638
- URN
-
urn:nbn:de:101:1-2023051315210494856601
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hörmann, Nikolas
- Kalchschmid, Christina
- Grabher, Patricia
- Grassmayr, Isabella
- Kapitza, Paul
- Kaserer, Teresa
- Gust, Ronald
Other Objects (12)
Estrogen Plus Estrogen Receptor Antagonists Alter Mineral Production by Osteoblasts In Vitro
Estrogen alpha receptor antagonists for the treatment of breast cancer: a review
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer
A single nucleotide polymorphism in the steroid receptor coactivator 1 and its implications for estrogen dependent diseases
Predictive features of ligand‐specific signaling through the estrogen receptor
Function of estrogen on bone and the characterization of the skeletal phenotype of steroid receptor coactivator (SRC)-1 KO mice
NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells
Development of an orthogonal ligand-receptor pair based on synthetic estrogen analogs and engineered estrogen receptor for transcriptional regulation
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
Flexible promoter architecture requirements for coactivator recruitment
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
Estrogen Plus Estrogen Receptor Antagonists Alter Mineral Production by Osteoblasts In Vitro
Estrogen alpha receptor antagonists for the treatment of breast cancer: a review
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer
A single nucleotide polymorphism in the steroid receptor coactivator 1 and its implications for estrogen dependent diseases
Predictive features of ligand‐specific signaling through the estrogen receptor
Function of estrogen on bone and the characterization of the skeletal phenotype of steroid receptor coactivator (SRC)-1 KO mice
NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells
Development of an orthogonal ligand-receptor pair based on synthetic estrogen analogs and engineered estrogen receptor for transcriptional regulation
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
Flexible promoter architecture requirements for coactivator recruitment
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
Estrogen Plus Estrogen Receptor Antagonists Alter Mineral Production by Osteoblasts In Vitro
Estrogen alpha receptor antagonists for the treatment of breast cancer: a review
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer
A single nucleotide polymorphism in the steroid receptor coactivator 1 and its implications for estrogen dependent diseases
Predictive features of ligand‐specific signaling through the estrogen receptor
Function of estrogen on bone and the characterization of the skeletal phenotype of steroid receptor coactivator (SRC)-1 KO mice
NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells
Development of an orthogonal ligand-receptor pair based on synthetic estrogen analogs and engineered estrogen receptor for transcriptional regulation
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
Flexible promoter architecture requirements for coactivator recruitment
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast